IGFBP-1, produced in the liver, has both IGF dependent and independent effects20, which may explain the finding that conditions characterized by hyperinsulinemia such as insulin resistance and metabolic syndrome are associated with decreased levels of IGFBP‐118,21,22. This evidence concerns the gene IGFBP1 and metabolic syndrome.